Company Filing History:
Years Active: 2002-2008
Title: Emilian V Racila: Innovator in Cancer Cell Isolation
Introduction
Emilian V Racila is a notable inventor based in Dallas, TX (US), recognized for his contributions to the field of cancer research. He holds 3 patents that focus on innovative methods for isolating circulating cancer cells, which are crucial for early detection and treatment of cancer.
Latest Patents
One of his latest patents involves methods and reagents for the rapid and efficient isolation of circulating cancer cells. This highly sensitive assay combines immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis. It is designed to detect, enumerate, and characterize carcinoma cells in the blood. Remarkably, the assay can detect one epithelial cell or less in 1 ml of blood, demonstrating greater sensitivity than conventional PCR or immunohistochemistry by 1-2 orders of magnitude. Additionally, this assay facilitates the biological characterization and staging of carcinoma cells.
Career Highlights
Throughout his career, Emilian has worked with various organizations, including Immunivest Corporation. His work has significantly advanced the methodologies used in cancer diagnostics and treatment.
Collaborations
Emilian has collaborated with esteemed professionals in his field, including Leon W M M Terstappen and Galla Chandra Rao. These collaborations have further enriched his research and innovations.
Conclusion
Emilian V Racila's work in the isolation of circulating cancer cells represents a significant advancement in cancer diagnostics. His innovative approaches continue to impact the field positively, paving the way for improved patient outcomes.